Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties
Tim Hempel, Katarina Elez, Nadine Krüger, et al.
Chemical Science (2021) Vol. 12, Iss. 38, pp. 12600-12609
Open Access | Times Cited: 19

Showing 19 citing articles:

Transformative Approaches in SARS-CoV-2 Management: Vaccines, Therapeutics and Future Direction
Ankita Saha, Shweta Choudhary, Priyanshu Walia, et al.
Virology (2025) Vol. 604, pp. 110394-110394
Closed Access | Times Cited: 1
Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 Patients
Giorgia Dinoi, Maria Vittoria Togo, Pietro Guida, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 535-535
Open Access | Times Cited: 1
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
Rui‐Sheng Wang, Joseph Loscalzo
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1374-1386
Open Access | Times Cited: 17
Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices
Tushar Saha, Miguel E. Quiñones‐Mateu, Shyamal C. Das
International Journal of Pharmaceutics (2022) Vol. 624, pp. 122042-122042
Open Access | Times Cited: 26
The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19
Christiana Mantzourani, Sofia Vasilakaki, Velisaria-Eleni Gerogianni, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 3, pp. 231-246
Open Access | Times Cited: 23
Stochastic Approximation to MBAR and TRAM: Batchwise Free Energy Estimation
Maaike M. Galama, Hao Wu, Andreas Krämer, et al.
Journal of Chemical Theory and Computation (2023) Vol. 19, Iss. 3, pp. 758-766
Open Access | Times Cited: 11
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal
Francesco Samarelli, Giovanni Graziano, Nicola Gambacorta, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 450-450
Open Access | Times Cited: 4
TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses
Gilmara Barros de Lima, Everton Nencioni, Fábio Thimoteo, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 75-75
Open Access
Inhaled Dry Powder of Antiviral Agents: A Promising Approach to Treating Respiratory Viral Pathogens
Tushar Saha, Zia Uddin Masum, Anik Naha Biswas, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 252-252
Open Access
Synthesize of β-Amino Esters from Enamides via 1,8-Diazabicyclo[5.4.0]undecane-7-ene-Mediated Hydroalkylation
Xiao Yang, Junyi Wang, Haoran Liang, et al.
The Journal of Organic Chemistry (2025)
Closed Access
Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
Hong Zhou, Wei‐Jian Ni, Wei Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Design, synthesis and biological evaluation of novel TMPRSS2-PROTACs with florosubstituted 4-guanidino-N-phenylbenzamide derivative ligands
Hao Yang, Haoran Xu, Xinxin Lin, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 116, pp. 117982-117982
Closed Access | Times Cited: 1
Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
Jonathan H. Shrimp, John Janiszewski, Catherine Z. Chen, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 6, pp. 1191-1203
Open Access | Times Cited: 7
N‐Pyridylureas as Masked Isocyanates Fort the Late‐Stage Diversification of Pyridine‐N‐Oxides
Svetlana O. Baykova, Sergey V. Baykov, Kirill K. Geyl, et al.
ChemistrySelect (2024) Vol. 9, Iss. 13
Closed Access
Integrating population-level and cell-based signatures for drug repositioning
Chunfeng He, Yue Xu, Yuan Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
Jonathan H. Shrimp, John Janiszewski, Catherine Z. Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Drug Repurposing Patent Applications January–March 2023
Hermann AM Mucke
Assay and Drug Development Technologies (2023) Vol. 21, Iss. 4, pp. 180-187
Closed Access
Identifying TMPRSS2 Inhibitors by Drug Repurposing Screenings of Known fXIa Inhibitors: A Computational Study
Yan-Shu Liang, Zhixia Qiao, Fancui Meng
Letters in Drug Design & Discovery (2022) Vol. 21, Iss. 3, pp. 590-601
Closed Access
Page 1

Scroll to top